Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease
Answers
Answered by
0
Explanation:
(i) Raisins in beaker A with plain water will get swollen due to endosmosis while raisins in beaker B with concentrated sugar solution will get shrink due to exosmosis.
(ii) Plain water is hypotonic while concentrated sugar solution is hypertonic.
Answered by
0
Hey!♥
____________________________
Median to time to second CMR was estimated as 7.3 months in re-treated patients. Conclusion: Loss of MMR is a practical and safe criterion for restarting therapy in patients with CML with prolonged CMR.
- Hope it helps!
Similar questions